Venous thromboembolism is associated with increased all-cause mortality in ALK-positive non-small cell lung cancer

Venous thromboembolic events (VTE) are often diagnosed in ALK-positive lung cancer although it has not been demonstrated how their co-occurrence affects patients' survival.